MLN9708 and Dexamethasone for High-Risk Smoldering Multiple Myeloma
by on Friday, August 10th, 2012 | No Comments
Condition: Multiple Myeloma
Interventions: Drug: MLN9708; Drug: Dexamethasone
Sponsors: National Institutes of Health Clinical Center (CC); National Cancer Institute (NCI)
Recruiting – verified July 2012
Read the original here: MLN9708 and Dexamethasone for High-Risk Smoldering Multiple Myeloma
